FDA Adverse Event Malfunction Summary report: N

ADVIA CENTAUR XP CEA ASSAY

MDR report key: 3140127 · Received May 31, 2013

Report

Report Number
1219913-2013-00134
Event Type
Malfunction
Date Received
May 31, 2013
Date of Event
May 13, 2013
Report Date
May 21, 2013
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Product Code
DHX
PMA / PMN Number
K981478
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE CAUSE FOR THE DISCORDANT ADVIA CENTAUR XP CEA RESULT IS UNKNOWN. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVALUATION FO THE DEVICE IS REQUIRED. THE INSTRUCTION FOR USE (IFU) LIMITATION SECTION STATES: "NOTE: DO NOT INTERPRET LEVELS OF CEA AS ABSOLUTE EVIDENCE OF THE PRESENCE OR THE ABSENCE OF MALIGNANT DISEASE. MEASUREMENTS OF CEA SHOULD ALWAYS BE USED IN CONJUNCTION WITH OTHER DIAGNOSTIC PROCEDURES, INCLUDING INFORMATION FROM THE PATIENT'S CLINICAL EVALUATION. THE CONCENTRATION OF CEA IN A GIVEN SPECIMEN DETERMINED WITH ASSAYS FROM DIFFERENT MANUFACTURERS CAN VARY DUE TO DIFFERENCES IN ASSAY METHODS, CALIBRATION, AND REAGENT SPECIFICITY. CEA DETERMINED WITH DIFFERENT MANUFACTURERS' ASSAYS WILL VARY DEPENDING ON THE METHOD OF STANDARDIZATION AND ANTIBODY SPECIFICITY. WARNING: DO NOT USE THE ADVIA CENTAUR CEA IMMUNOASSAY AS A SCREENING TEST FOR DIAGNOSIS."

Description of Event or Problem · 1

A LOW ADVIA CENTAUR XP CEA RESULT WAS OBTAINED ON A PATIENT SAMPLE. REPEAT TESTING WAS PERFORMED AND THE RESULTS WERE LOW. THE PATIENT SAMPLE WAS TESTED ON TWO DIFFERENT ALTERNATE METHODS AND THE RESULTS WERE POSITIVE. THE PATIENT'S HEALTH CHECKUP IS THE REASON FOR CEA MEASUREMENTS AND DUE TO NO INDICATION OF A CANCER DIAGNOSIS. PATIENT TREATMENT WAS NOT ALTERED OR PRESCRIBED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT ADVIA CENTAUR XP CEA RESULT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
242138 ADVIA CENTAUR XP CEA ASSAY CEA IMMUNOASSAY DHX SIEMENS HEALTHCARE DIAGNOSTICS, INC. N/A 148

Patients

Seq Age Sex Outcome Treatment
1 72 YR